Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adult focal β-cell nesidioblastosis: A case report. | World J Clin Cases | 2023 | 36687197 | PubTator, text mining | PubMed |
| Immunohistochemical somatostatin receptor expression in insulinomas. | APMIS | 2023 | 36680557 | PubTator, text mining | PubMed |
| Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals. | Pharmaceutics | 2023 | 36678906 | PubTator, text mining | PubMed |
| Special Issue "G Protein-Coupled Receptors: Molecular Mechanisms Involved in Receptor Activation and Selectivity". | Life (Basel) | 2023 | 36676115 | PubTator, text mining | PubMed |
| Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. | Diagnostics (Basel) | 2023 | 36673128 | PubTator, text mining | PubMed |
| [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy. | Diagnostics (Basel) | 2023 | 36673078 | PubTator, text mining | PubMed |
| The Impact of PET/CT on Paediatric Oncology. | Diagnostics (Basel) | 2023 | 36673002 | PubTator, text mining | PubMed |
| Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET. | Cancers (Basel) | 2023 | 36672462 | PubTator, text mining | PubMed |
| Al[18F]F-NOTA-Octreotide Is Comparable to [68Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population. | Cancers (Basel) | 2023 | 36672388 | PubTator, text mining | PubMed |
| Novel Approach for Assessing Postinfarct Myocardial Injury and Inflammation Using Hybrid Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging. | Circ Cardiovasc Imaging | 2023 | 36649455 | PubTator, text mining | PubMed |
| Nuclear Methods for Immune Cell Imaging: Bridging Molecular Imaging and Individualized Medicine. | Circ Cardiovasc Imaging | 2023 | 36649445 | PubTator, text mining | PubMed |
| A topographic atlas defines developmental origins of cell heterogeneity in the human embryonic lung. | Nat Cell Biol | 2023 | 36646791 | PubTator, text mining | PubMed |
| Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators. | Transl Res | 2023 | 36640905 | PubTator, text mining | PubMed |
| Radiotheranostics in oncology: Making precision medicine possible. | CA Cancer J Clin | 2023 | 36622841 | PubTator, text mining | PubMed |
| Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates. | Asia Ocean J Nucl Med Biol | 2023 | 36619190 | PubTator, text mining | PubMed |
| Peptide Drug Conjugates and Their Role in Cancer Therapy. | Int J Mol Sci | 2023 | 36614268 | PubTator, text mining | PubMed |
| 68Ga-DOTATOC PET in Extracranial Hepatic and Bone Metastasis of Atypical Refractory Meningioma: A Case Report. | Clin Nucl Med | 2023 | 36607366 | PubTator, text mining | PubMed |
| In silico Study on the Binding Interactions of SSTA and 18F-SSTA Towards Somatostatin Receptor Subtype 2. | Anticancer Agents Med Chem | 2023 | 36600623 | PubTator, text mining | PubMed |
Gene's expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study. | J Transl Med | 2023 | 36600265 | PubTator, text mining | PubMed |
| Filamin A organizes γ‑aminobutyric acid type B receptors at the plasma membrane. | Nat Commun | 2023 | 36596803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=37